Literature DB >> 16959275

Effects of nicotine exposure during prenatal or perinatal period on cell numbers in adult rat hippocampus and cerebellum: a stereology study.

Wei-Jung A Chen1, Karen A King, Ruby E Lee, Christopher S Sedtal, Andrew M Smith.   

Abstract

Smoking during pregnancy poses a potential risk to unborn children. The present study examined the long-term effects of early nicotine exposure on the number of pyramidal and granule cells in the hippocampus, and Purkinje cells in the cerebellar vermis. The loss of neurons is the most severe form of brain injury with significant functional implications. In this study, rats were exposed to nicotine during either the prenatal (PRE) period or both the prenatal and early postnatal (PERI) period. It was hypothesized that nicotine treatment would result in long-term decreases in neuronal numbers, and that PERI treatment would be more detrimental to these cell populations than the PRE treatment. The results showed that neither PRE nor PERI nicotine exposure reduces the numbers of pyramidal, granule or Purkinje cells. Neither the regions where these cells reside, nor the cell densities were affected by nicotine. Although no significant cell loss was observed, the current nicotine exposure regimens may lead to alterations in cellular functions or cytoarchitectures. The present results in conjunction with previous reports showing significant cell loss from nicotine exposure during the brain growth spurt suggest that "patch-like" nicotine exposure during prenatal period may alter the sensitivity or the responsiveness of the developing brain to the injurious effects of nicotine during the most vulnerable stage of brain development - the brain growth spurt. Furthermore, the current stereology cell counting results are not in agreement with some reports in the literature, and this discrepancy may simply be a function of different cell counting techniques used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959275     DOI: 10.1016/j.lfs.2006.07.019

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Lower glial metabolite levels in brains of young children with prenatal nicotine exposure.

Authors:  Linda Chang; Christine C Cloak; Caroline S Jiang; Aaron Hoo; Antonette B Hernandez; Thomas M Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-13       Impact factor: 4.147

2.  Developmental nicotine exposure alters neurotransmission and excitability in hypoglossal motoneurons.

Authors:  Jason Q Pilarski; Hilary E Wakefield; Andrew J Fuglevand; Richard B Levine; Ralph F Fregosi
Journal:  J Neurophysiol       Date:  2010-11-10       Impact factor: 2.714

3.  Enhanced susceptibility of CA3 hippocampus to prenatal nicotine exposure.

Authors:  O O Kalejaiye; M C Gondré-Lewis
Journal:  J Dev Orig Health Dis       Date:  2016-12-28       Impact factor: 2.401

4.  Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins.

Authors:  Janet K Kern; David A Geier; Françoise Ayzac; James B Adams; Jyutika A Mehta; Mark R Geier
Journal:  Toxicol Environ Chem       Date:  2010-08-12       Impact factor: 1.437

Review 5.  Differential Effects of Nicotine Exposure on the Hippocampus Across Lifespan.

Authors:  Dana Zeid; Munir Gunes Kutlu; Thomas J Gould
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Behavioral and Gene Regulatory Responses to Developmental Drug Exposures in Zebrafish.

Authors:  Aleksandra M Mech; Munise Merteroglu; Ian M Sealy; Muy-Teck Teh; Richard J White; William Havelange; Caroline H Brennan; Elisabeth M Busch-Nentwich
Journal:  Front Psychiatry       Date:  2022-01-10       Impact factor: 4.157

7.  Prenatal nicotine and maternal deprivation stress de-regulate the development of CA1, CA3, and dentate gyrus neurons in hippocampus of infant rats.

Authors:  Hong Wang; Marjorie C Gondré-Lewis
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.